Celltrion’s CT-P59 Antiviral Candidate Reduces COVID-19 Virus 100-Fold
Celltrion announced on Monday that its antiviral treatment candidate CT-P59 for COVID-19 positively lowered the amount of SARS-CoV-2 virus in ...
Celltrion announced on Monday that its antiviral treatment candidate CT-P59 for COVID-19 positively lowered the amount of SARS-CoV-2 virus in ...
Seegene Inc., on Wednesday, announced that its COVID-19 test kit, Allplex™ 2019-nCoV Assay, received Emergency Use Authorization (EUA) from the ...
Osang Healthcare announced that it received approval from the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) ...
The Korea Institute for Basic Science (IBS) announced that it completed the world’s first high-resolution genetic map for the SARS-COV-2, ...
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |